2025 Event

World Drug Safety Congress Americas

Date: November 4th-6th, 2025
Location: Boston, MA, U.S.

Booth: 306

Discover Cencora at World Drug Safety Congress Americas 2025

The World Drug Safety Congress Americas 2025 in Boston provides a platform for discussing advancements in AI, quality assurance, and signal management to improve drug safety processes. Come and meet our team at the conference to network and discuss key safety processes, including: 
  • PV system governance: EU QPPV, PSMF, PV agreement management, quality systems, training, PV audits & inspections
  • Local Affiliate PV services: National contact person & all local services
  • PV operational support: Literature surveillance, ICSR management, safety reporting 
  • Benefit-risk management: data-driven insights for decision-making 
  • AI-enhanced technologies: digitized solutions & intelligent automation 

Expert session

Harnessing AI and Advanced Analytics to Revolutionize Pharmacovigilance Signal Management 

Pharmacovigilance lies at the heart of patient safety, with signal detection and assessment serving as its cornerstone. However, the growing volume of complex, often unstructured patient data presents significant challenges in identifying, assessing, and acting on safety signals efficiently. Artificial intelligence (AI) and advanced analytics are reshaping the landscape of pharmacovigilance, offering new opportunities to enhance signal management processes. 

In this talk, we explore how cutting-edge techniques—such as natural language processing, generative AI, machine learning, and Bayesian statistics—can be applied to unlock the full potential of pharmacovigilance. We will showcase applications that demonstrate how these tools streamline data harmonization, improve signal detection accuracy, and accelerate decision-making. Additionally, we will highlight best practices for ensuring transparency, ethical implementation, and regulatory compliance when adopting these advanced technologies. Finally, we’ll provide insights into the outlook of AI-powered pharmacovigilance, emphasizing its role in creating smarter, more proactive drug safety systems. 

Presenters: Lin Li, Head of Clinical Statistics & Computational Biology at Cencora; Stephen Sun, VP, US Pharmacovigilance, Epidemiology, and Risk Management at Cencora
Date: Wednesday, November 5, 2025, 2:00 - 2:20 PM ET 
Location: Next Gen Tech & Data |Theater 6 - Room 052A

Connect with us at the booth #313

Lin Li, Ph.D. 
Head of Clinical Statistics & Computational Biology
Stephen Sun
VP, Pharmacovigilance, Epidemiology & Risk Management, U.S.
Daniel Koppers
Head of Research & Development
Alexander Schwind
Director, Portfolio Governance, Digital Innovation 
Sarina Thapar
Specialist, Pharmacovigilance, Epidemiology & Risk Management
Ricky Echols
Director, U.S. 

With team across North America, Europe, and Asia-Pacific region, we blend global reach with local expertise

3,000
Consultants worldwide
30+
Global markets covered
235+
Brands represented

Helping breakthroughs break through
 

At Cencora, we’re leading the way to a place where your life-changing therapies can soar to impossible heights. Together, let’s create healthier futures for more patients around the globe.

Maximize patient safety and minimize risk throughout your product life cycle

Patient safety is a primary mandate of every health authority worldwide and we know that pharmacovigilance (PV) teams are facing growing operational challenges and resource constraints. That's why we offer local and global pharmacovigilance services to improve the success of product launches and post-market growth, while freeing up safety and clinical teams to focus on strategic priorities. Our customers gain a competitive edge with access to more than 1000 subject matter experts and native resources in over 150 countries.

Meet with us at World Drug Safety Congress Americas

Interested in learning more? We're here to answer questions and to support your Pharmacovigilance needs. Schedule time to meet with our team at the event.

Cencora.com fournit des traductions automatiques pour faciliter la lecture du site Web dans des langues autres que l’anglais. Pour ces traductions, des efforts raisonnables ont été faits pour fournir une traduction précise, cependant, aucune traduction automatique n’est parfaite et n’est pas destinée à remplacer les traducteurs humains. Ces traductions sont fournies à titre de service aux utilisateurs de Cencora.com et sont fournies « en l’état ». Aucune garantie d’aucune sorte, expresse ou implicite, n’est donnée quant à l’exactitude, la fiabilité ou l’exactitude de l’une ou l’autre de ces traductions effectuées de l’anglais vers une autre langue. Certains contenus (tels que les images, les vidéos, Flash, etc.) peuvent ne pas être traduits avec précision en raison des limitations du logiciel de traduction.

Toute divergence ou différence créée lors de la traduction de ce contenu de l’anglais vers une autre langue n’est pas contraignante et n’a aucun effet juridique pour la conformité, l’application ou toute autre fin. Si des erreurs sont identifiées, veuillez nouscontacter. Si vous avez des questions concernant l’exactitude des informations contenues dans ces traductions, veuillez vous référer à la version anglaise de la page.